Holista Colltech (ASX:HCT) and Ultraverse secured a grant equivalent to AU$163,000 from NanoMalaysia to develop a process to manufacture halal-certified ovine nano-collagen, according to a Tuesday Australian bourse filing.

NanoMalaysia is a business entity under Malaysia's Ministry of Science, Technology, and Innovation entrusted to commercialize nanotechnology. Holista plans to file a patent for halal nano-collagen. It is also in talks with the government of the Malaysian state of Sarawak to enter into a joint venture to establish a facility within the biotech hub to manufacture halal nano-collagen.

Further, the firm partnered with India-based Akrivis Health Care to develop nano-collagen that is less than 100 nanometers. In May 2023, Holista applied to the US Patent and Trademark Office to file a patent on nano-collagen. This application reached the public publication phase in November 2024.

It said that Regenerex will start clinical studies in the June quarter to use Holista's nano-collagen for wound healing. It plans to complete a licensing agreement with Regenerex, which intends to market the nano-collagen in international markets.

The firm ceased its operations in Collie in Western Australia on the expiry of a 20-year lease.

It submitted an application to the Collie Futures Small Grants Program for a grant of AU$100,000 to support a new modular collagen production facility in Collie. Manufacturing at the new facility will use modified shipping containers customized to house specialized equipment, production lines, and storage areas.

The new facility is expected to be established in early 2026.